Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Assets Average (2024 - 2025)

CG Oncology filings provide 2 years of Assets Average readings, the most recent being $760.8 million for Q4 2025.

  • On a quarterly basis, Assets Average rose 16.39% to $760.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $760.8 million, a 16.39% increase, with the full-year FY2025 number at $773.2 million, up 62.08% from a year prior.
  • Assets Average hit $760.8 million in Q4 2025 for CG Oncology, up from $715.7 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $760.8 million in Q4 2025 to a low of $389.2 million in Q1 2024.